Gregory Korbel

Chief Operating Officer presso Atrin Pharmaceuticals, Inc.

Patrimonio netto: 7 178 $ in data 31/03/2024

48 anni

Health Technology

Consumer Services

Profilo

Gregory A.
Korbel is currently the Chief Operating Officer at Atrin Pharmaceuticals, Inc. He previously worked as the Director of Research Operations at Johnson & Johnson.
From 2012 to 2015, he was the Director of Business Development & Operations at Novira Therapeutics LLC.
From 2022 to 2023, he was the Chief Operating Officer & Senior Vice President at Aprea Therapeutics, Inc. Korbel holds a doctorate from Harvard University, an undergraduate degree from Vanderbilt University, and an MBA from The Wharton School of the University of Pennsylvania.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
APREA THERAPEUTICS, INC. 0.02%	26/06/2023	1 073 ( 0.02% )	7 178 $	31/03/2024

Posizioni attive di Gregory Korbel

Società	Posizione	Inizio
Atrin Pharmaceuticals, Inc. Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile.	Chief Operating Officer	-

Tutte le posizioni attive di Gregory Korbel

Precedenti posizioni note di Gregory Korbel

Società	Posizione	Fine
APREA THERAPEUTICS, INC.	Chief Operating Officer	31/03/2023
Novira Therapeutics LLC Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA.	Chief Operating Officer	01/12/2015
JOHNSON & JOHNSON	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Gregory Korbel

Formazione di Gregory Korbel

Harvard University	Doctorate Degree
Vanderbilt University	Undergraduate Degree
The Wharton School of the University of Pennsylvania	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gregory Korbel

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
JOHNSON & JOHNSON	Health Technology
APREA THERAPEUTICS, INC.	Health Technology

Aziende private	2
Atrin Pharmaceuticals, Inc. Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile.	Health Technology
Novira Therapeutics LLC Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA.	Health Technology